SQI Diagnostics has received the go-ahead in Canada to market its Ig_plex Celiac DGP Panel for clinical lab use. The multiplexed panel, which runs on the company's sqid-X platform, is designed to help clinicians rapidly detect celiac disease by quantifying key biomarkers linked to the illness, CEO Andrew Morris said.

Related Summaries